These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 8578849

  • 21. A comparative study on the immune response of sheep to foot and mouth disease virus vaccine type Asia-1 prepared with different inactivants and adjuvants.
    Nair SP, Sen AK.
    Comp Immunol Microbiol Infect Dis; 1992 Apr; 15(2):117-24. PubMed ID: 1314158
    [Abstract] [Full Text] [Related]

  • 22. Safety and efficacy of foot-and-mouth disease vaccines containing endonuclease-inactivated virions.
    Amadori M, Barei S, Melegari M, Panina GF.
    Vaccine; 1987 Sep; 5(3):219-22. PubMed ID: 2823495
    [Abstract] [Full Text] [Related]

  • 23. Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis.
    Viktorova EG, Khattar SK, Kouiavskaia D, Laassri M, Zagorodnyaya T, Dragunsky E, Samal S, Chumakov K, Belov GA.
    J Virol; 2018 Sep 01; 92(17):. PubMed ID: 29925653
    [Abstract] [Full Text] [Related]

  • 24. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B, Visser N, Theron J, Rieder E, Maree FF.
    J Gen Virol; 2011 Apr 01; 92(Pt 4):849-59. PubMed ID: 21177923
    [Abstract] [Full Text] [Related]

  • 25. An overview of the inactivation of FMDV and the implications when residual virus is present in vaccines.
    Brown F.
    Dev Biol Stand; 1991 Apr 01; 75():37-41. PubMed ID: 1665462
    [Abstract] [Full Text] [Related]

  • 26. [Routine physico-chemical testing of concentrated virulent and inactivated foot-and-mouth disease virus antigens].
    Adamowicz P, Guerche J, Galampoix J, Prunet P.
    Dev Biol Stand; 1976 Apr 01; 35():301-10. PubMed ID: 198300
    [Abstract] [Full Text] [Related]

  • 27. Use of N-acetylethyleneimine [AEI] for the inactivation of Semliki Forest virus in vitro.
    Amor S, Webb HE.
    J Med Virol; 1986 Aug 01; 19(4):367-76. PubMed ID: 3746260
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC, Chou AH, Lien SP, Lin HY, Liu SJ, Chang JY, Guo MS, Chow YH, Yang WS, Chang KH, Sia C, Chong P.
    Vaccine; 2011 Jun 10; 29(26):4362-72. PubMed ID: 21501643
    [Abstract] [Full Text] [Related]

  • 30. Inactivation of foot-and-mouth disease virus vaccine strains by activation of virus-associated endonuclease.
    Scodeller EA, Lebendiker MA, Dubra MS, Crespo OA, Basarab O, La Torre JL, Vasquez C.
    J Gen Virol; 1984 Sep 10; 65 ( Pt 9)():1567-73. PubMed ID: 6088682
    [Abstract] [Full Text] [Related]

  • 31. Stabilizing the immunizing antigen of foot-and-mouth disease virus by fixation with formaldehyde.
    Rowlands DJ, Sangar DV, Brown F.
    Arch Gesamte Virusforsch; 1972 Sep 10; 39(1):274-83. PubMed ID: 4344146
    [No Abstract] [Full Text] [Related]

  • 32. [Trials of vaccination of pigs with vaccines of inactivated foot-and-mouth disease (FMD) virus. II. Trials with ethyl ethyleneimine (EEI) inactivated virus and diethylaminoethyl dextran as an adjuvant].
    Wittmann G, Bauer K, Mussgay M.
    Arch Gesamte Virusforsch; 1970 Sep 10; 29(2):139-58. PubMed ID: 4316760
    [No Abstract] [Full Text] [Related]

  • 33. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
    McKenna TS, Rieder E, Lubroth J, Burrage T, Baxt B, Mason PW.
    J Biotechnol; 1996 Jan 26; 44(1-3):83-9. PubMed ID: 8717390
    [Abstract] [Full Text] [Related]

  • 34. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde.
    Barteling SJ, Cassim NI.
    Dev Biol (Basel); 2004 Jan 26; 119():449-55. PubMed ID: 15742659
    [Abstract] [Full Text] [Related]

  • 35. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
    Warrington RE, Cunliffe HR, Bachrach HL.
    Am J Vet Res; 1973 Aug 26; 34(8):1087-91. PubMed ID: 4356910
    [No Abstract] [Full Text] [Related]

  • 36. Effect of formaldehyde inactivation on poliovirus.
    Wilton T, Dunn G, Eastwood D, Minor PD, Martin J.
    J Virol; 2014 Oct 26; 88(20):11955-64. PubMed ID: 25100844
    [Abstract] [Full Text] [Related]

  • 37. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen.
    Sen AK, Saha SN.
    Acta Virol; 1994 Feb 26; 38(1):17-9. PubMed ID: 8067308
    [Abstract] [Full Text] [Related]

  • 38. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.
    Bhat SA, Saravanan P, Hosamani M, Basagoudanavar SH, Sreenivasa BP, Tamilselvan RP, Venkataramanan R.
    Res Vet Sci; 2013 Dec 26; 95(3):1217-23. PubMed ID: 23969204
    [Abstract] [Full Text] [Related]

  • 39. [Foot-and-mouth disease in buffaloes (Bubalus bubalis, Linnaeus, 1758): search of antiantigen antibodies and isolation of the virus].
    Jerez JA, Pinto AA, Arruda NV, Koseki I, Abuhab TG, Rodrigues MA.
    Arq Inst Biol (Sao Paulo); 1979 Dec 26; 46(3-4):111-5. PubMed ID: 233417
    [Abstract] [Full Text] [Related]

  • 40. Inactivation of poliovirus with beta-propiolactone.
    Jiang SD, Pye D, Cox JC.
    J Biol Stand; 1986 Apr 26; 14(2):103-9. PubMed ID: 3020055
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.